
NCLT Sanctions Amalgamation of J. B. Chemicals into Torrent Pharmaceuticals
Torrent Pharmaceuticals Limited has successfully completed a significant corporate restructuring milestone with the sanctioning of its amalgamation scheme by the National Company Law Tribunal (NCLT). The Hon'ble NCLT issued the order on July 6, 2026, sanctioning the merger of J. B. Chemicals & Pharmaceuticals Limited into Torrent Pharmaceuticals Limited and their respective shareholders.The Scheme involves the transferor company, J. B. Chemicals & Pharmaceuticals Limited, integrating with the transferee company, Torrent Pharmaceuticals Limited. This amalgamation is governed by Sections 230 to 232 and other applicable provisions of the Companies Act, 2013.
According to the approved scheme, the companies will proceed following the receipt of the NCLT order. The Scheme of Amalgamation will officially become effective upon the filing of the certified copy of the Order with the Registrar of Companies. Torrent Pharmaceuticals Limited has confirmed that it will inform the Stock Exchange of the official effective date once the scheme becomes operational.
TORNTPHARM Stock Price Movement
Torrent Pharmaceuticals Limited closed today having gained 1.04%, settling at ₹4822.7, as the shares achieved a significant milestone by hitting their 52-week high. The stock traded 271,017 shares in the session, capping off a strong day for the pharmaceuticals sector.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.